September price hold at SemaPen: time to decide with clinical support

Ready to take the next step? See if you're eligible for expert-led weight loss support.

Check your eligibility

September price hold at SemaPen: time to decide with clinical support

Mounjaro® pricing at SemaPen: September first month £159, then dose-based pricing

Many patients are weighing up next steps. To support calm, informed choices, we’re absorbing most of the Mounjaro® price rise through September for new and existing patients.


That means:


New starters: first month £159 with code WELCOME


From month two / existing patients:


  • 2.5 mg £199
  • 5 mg £225
  • 7.5 mg £249
  • 10 mg £275
  • 12.5 mg £289
  • 15 mg £299


This buys time to talk with our clinicians, adjust dose if appropriate, or consider Wegovy, which remains unchanged in price.

We expect to review pricing from 1 October 2025. Until then, our focus is continuity of care and helping you choose what suits you best.



Questions about your plan or next order?


Message us in the SemaPen app or call 01244 738 163.


The £159 first month applies to new patients who start in September and are clinically eligible.

  • Average 15-21% weight loss*
  • Tailored programmes built by real experts
  • Targeted support to make success feel simpler
  • Unique app with weight loss tools and lessons

Your journey starts here

Start your personalised weight loss plan in minutes.

1

Start your online consultation

2

Get approved by our clinical team

3

Begin your programme

Get started
How many calories should you eat on Mounjaro? Learn what the NHS recommends for safe weight loss
by Simon Edward • 12 October 2026
How many calories should you eat on Mounjaro? Learn what the NHS recommends for safe weight loss and how Mounjaro fits in.
Wondering if weight loss can cause depression? The simple answer: it depends on how you do it.
by Simon Edward • 9 October 2026
Wondering if weight loss can cause depression? The simple answer: it depends on how you do it.
Obesity is a leading cause of obstructive sleep apnoea.
by Simon Edward • 5 October 2026
Obesity is a leading cause of obstructive sleep apnoea. Does that mean weight loss injections can help? Let's look at the evidence.
Wondering where you'll notice weight loss first? Discover the early signs of fat loss
by Simon Edward • 2 October 2026
Wondering where you'll notice weight loss first? Discover the early signs of fat loss and why it's worth celebrating achievements beyond the scale.
A recent trial tested Wegovy for weight loss in children aged 6 to 11.
by Simon Edward • 30 September 2026
A recent trial tested Wegovy for weight loss in children aged 6 to 11. Does that mean younger children will soon be able to access the drug?
Retatrutide is an experimental weight loss drug that's not approved for treatment anywhere.
by Simon Edward • 28 September 2026
Retatrutide is an experimental weight loss drug that's not approved for treatment anywhere. So, why are websites offering it for sale in 2026?
Explore the fastest medically supervised weight loss options, from GLP-1 injections
by Simon Edward • 11 September 2026
Explore the fastest medically supervised weight loss options, from GLP-1 injections to total diet replacement, and learn why speed isn't everything.
Non-surgical weight loss procedures may help you lose weight without conventional surgery.
by Simon Edward • 1 September 2026
Non-surgical weight loss procedures may help you lose weight without conventional surgery. Learn about your options and which might suit you.
A new GLP-1 drug called 'avexitide' is in development, but it works very differently from Wegovy.
by Simon Edward • 31 August 2026
A new GLP-1 drug called 'avexitide' is in development, but it works very differently from Wegovy and Mounjaro. Get the facts in our guide.
Learn how medically supervised total diet replacement (TDR) programmes work
by Simon Edward • 28 August 2026
Learn how medically supervised total diet replacement (TDR) programmes work, who they're suitable for and what the evidence says.
More posts